Assistant Professor, Medicine, University of Colorado School of Medicine
Oncology
Dr. Colin D. Weekes, MD
|
|
Give Review
Colin Weekes is an expert in the field of Oncology. He went to medical school at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Colin Weekes has written publications. He has 18 publications published with PubMed. The lastest publication is: 'Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival.' Colin D. Weekes is registered with Medicare.
Publications
- Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic p...
- A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid Tumors.
- A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid Tumors.
- Phase 1 study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid Malignancies.
- hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung Cancer cells via targeting MDM2 expres...
- Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal Cancer.
- Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer.
- Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatoCellular carcinoma.
- ExtraCellular cyclophilin-A stimulates ERK1/2 phosphorylation in a Cell-dependent manner but broadly stimulates nuclear factor kappa B.
- Patient-derived tumour xenografts as models for oncology drug development.
- Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors...
- A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung Cancer.
- Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic Cancer.
- Hodgkin''s disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.
- VLA-4 mediated adhesion to bone marrow stromal Cells confers chemoresistance to adherent lymphoma Cells.
- Lymphoma Cells associated with bone marrow stromal Cells in culture exhibit altered growth and survival.
- A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas Cancer.
Schools
University Of Nebraska College Of Medicine
University Of Alabama Hospital Program
Johns Hopkins UniversityUniversity Of Maryland Program
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Alabama Medical Center -
University of Nebraska College of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1043366750 | |
| NPPES Provider LastName | WEEKES | |
| NPPES Provider FirstName | COLIN | |
| NPPES Provider ZIPCode | 800457402 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043366750 |
| Last Name Of The Provider | WEEKES |
| First Name Of The Provider | COLIN |
| View All |
Similar Doctors
|
Dr. Han Myint, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jonathan A. Gutman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Stephen Leong, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. L Michael Glode, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eun-Kyung Im, MD |
|
Dr. Wells A. Messersmith, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|